CSIMarket



West Pharmaceutical Services Inc.  (WST)
Other Ticker:  
 

West Pharmaceutical Services's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Equity Change 19.28 % 27.18 % 25.93 % 28.12 % -
Y / Y Net Income Change 0.64 % 14.95 % 50.1 % 113.37 % 105.37 %
Net Income (TTM) in Millions 686 684 662 613 519
Return On Equity (TTM) 29.53 % 30.77 % 31.52 % 30.94 % 27.93 %
Total Ranking # 559 # 532 # 515 # 513 # 591
Equity (TTM) in Millions 2,424 2,326 2,335 2,202 2,033
Seq. Equity Change 4.22 % -0.39 % 6.04 % 8.35 % 11.13 %
Seq. Net Income Change 8.46 % 17.67 % -15.89 % -6.25 % 23.88 %


Roe Comment
West Pharmaceutical Services Inc. returned in II. Quarter 29.53 % on shareholder's equity, and it was higher than West Pharmaceutical Services average return on equity.

ROE detoriated compare to previous period, despite net income growth.

Within Healthcare sector 55 other companies have achieved higher return on equity. While Return on equity total ranking has deteriorated compare to previous quarter from 536 to 563.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 7
Sector # 56
Overall # 561

Return On Equity Statistics
High Average Low
31.52 %
17.49 %
8.31 %
(Dec 31 2021)   (March 31, 2016)


Annual Return On Equity (Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
Total Equity in Millions 2,335 1,855 1,573 1,396 1,280
Y / Y Equity Change 25.93 % 17.88 % 12.67 % 9.09 % 14.53 %
Net Income in Millions 662 346 242 207 151
Y / Y Net Income Change 91.16 % 43.24 % 16.82 % 37.29 % 4.94 %
Return On Equity 28.34 % 18.67 % 15.36 % 14.82 % 11.77 %





Annual Roe Comment
In 2021 ROE improved to 28.34 % compare to previous year, due to net income growth.


Financial Statements
West Pharmaceutical Services's Equity $ 2,424 Millions WST's Balance sheet
West Pharmaceutical Services's Income $ 189 Millions Quarterly WST's Income Statement
WST's Income by Division See WST's Income by Division

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
WST's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for WST's Competitors
Return On Equity for West Pharmaceutical Services's Suppliers
Roe for WST's Customers

You may also want to know
WST's Roa WST's Inventory Turnover Ratio WST's Growth Rates WST's Dividend Statistics
WST's Profitability Ratios WST's Asset Turnover Ratio WST's Dividend Growth
WST's Roi WST's Valuation Ratios WST's Financial Strength Ratios WST's Dividend Payout Ratio



Companies with similar Return On Equity at Jun 30 2022, within Healthcare Sector ROE
Avalo Therapeutics Inc.  81.00 %
Harpoon Therapeutics Inc.  80.40 %
Sensus Healthcare Inc.  74.85 %
Tenet Healthcare Corp  74.11 %
Vir Biotechnology Inc.  68.86 %
Oncotelic Therapeutics Inc.  68.05 %
Biofrontera Inc.  65.87 %
Eli Lilly And Company  64.62 %
Iteos Therapeutics Inc.  60.26 %
180 Life Sciences Corp.  59.53 %
Vyne Therapeutics Inc.  54.91 %
Siga Technologies Inc  48.79 %
Glucotrack Inc.  47.72 %
Reflect Scientific Inc  47.53 %
National Research Corporation  45.39 %
Zoetis Inc.  45.24 %
Prophase Labs Inc.  43.98 %
Merck and Co. Inc.  41.90 %
Enact Holdings Inc.  41.81 %
Innoviva Inc.  38.87 %
Cryo cell International Inc.  38.23 %
Chemed Corporation  37.40 %
Quidelortho Corp  36.94 %
Pfizer Inc  36.26 %
Hanger inc.  34.41 %
Lftd Partners Inc.  33.22 %
Exelixis Inc.  32.88 %
Chemomab Therapeutics Ltd.  32.70 %
Hologic Inc  32.61 %
Fulgent Genetics Inc.  32.32 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BRDS's Profile

Stock Price

BRDS's Financials

Business Description

Fundamentals

Charts & Quotes

BRDS's News

Suppliers

BRDS's Competitors

Customers & Markets

Economic Indicators

BRDS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071